🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has removed violative content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

Within moments of entering one group, a seller posted contact information, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.